Macrogenics Inc (MGNX)

3.31 -11.36 (-77.44%) USD  |  NASDAQ  |  May 10, 16:00
3.31 0.00 (0.00%) After-Hours: 20:00
More

Macrogenics Research and Development Expense (TTM): 166.58M for Dec. 31, 2023

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 166.58M
September 30, 2023 164.89M
June 30, 2023 182.95M
March 31, 2023 191.46M
December 31, 2022 207.03M
September 30, 2022 217.23M
June 30, 2022 218.86M
March 31, 2022 222.89M
December 31, 2021 214.58M
September 30, 2021 201.02M
June 30, 2021 195.86M
March 31, 2021 197.43M
December 31, 2020 193.20M
September 30, 2020 202.86M
June 30, 2020 203.05M
March 31, 2020 197.14M
December 31, 2019 195.31M
September 30, 2019 190.28M
June 30, 2019 191.64M
March 31, 2019 192.22M
December 31, 2018 190.83M
September 30, 2018 182.89M
Date Value
June 30, 2018 177.65M
March 31, 2018 160.10M
December 31, 2017 147.23M
September 30, 2017 139.36M
June 30, 2017 128.67M
March 31, 2017 127.55M
December 31, 2016 122.09M
September 30, 2016 121.03M
June 30, 2016 114.83M
March 31, 2016 104.15M
December 31, 2015 98.27M
September 30, 2015 87.88M
June 30, 2015 82.41M
March 31, 2015 77.08M
December 31, 2014 70.19M
September 30, 2014 64.88M
June 30, 2014 57.34M
March 31, 2014 51.05M
December 31, 2013 46.58M
September 30, 2013 40.74M
June 30, 2013 41.62M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

164.89M
Minimum
Sep 2023
222.89M
Maximum
Mar 2022
197.59M
Average
197.14M
Median
Mar 2020

Research and Development Expense (TTM) Benchmarks

Moderna Inc 4.777B
Allurion Technologies Inc 27.70M
United Therapeutics Corp 429.20M
MEI Pharma Inc 25.07M
Marinus Pharmaceuticals Inc 99.39M